We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Arthur J. Gallagher & Co
AJG
$65.9B
| $69.6M | 0.17% |
731,100
+104,700
| +17% | +$9.59M |
|
152
Textron
TXT
$15B
| $69.6M | 0.17% |
1,560,780
+276,251
| +22% | +$12.8M |
|
153
Advanced Micro Devices
AMD
$791B
| $69.3M | 0.17% |
1,511,500
+231,577
| +18% | +$8.52M |
|
154
Owens Corning
OC
$11.2B
| $69.1M | 0.17% |
1,061,443
-400,000
| -27% | -$25.6M |
|
155
Southwest Gas
SWX
$6.54B
| $68.9M | 0.17% |
906,767
-261,643
| -22% | -$21.3M |
|
|
SCHW
156
Charles Schwab
SCHW
$181B
| $68.8M | 0.17% |
1,446,500
+11,800
| +0.8% | +$520K |
|
157
Colgate-Palmolive
CL
$73.3B
| $68.8M | 0.17% |
999,220
-37,700
| -4% | -$2.57M |
|
158
Stryker
SYK
$133B
| $68.3M | 0.17% |
325,452
-64,345
| -17% | -$13.4M |
|
159
Ecolab
ECL
$78.6B
| $68.3M | 0.17% |
353,980
+91,100
| +35% | +$17.3M |
|
160
Goldman Sachs
GS
$302B
| $68.2M | 0.17% |
296,800
-152,100
| -34% | -$33M |
|
161
Public Service Enterprise Group
PEG
$38.6B
| $67.7M | 0.17% |
1,146,744
-478,000
| -29% | -$29M |
|
162
Westlake Corp
WLK
$9.19B
| $67.4M | 0.17% |
961,268
-293,533
| -23% | -$19.7M |
|
|
LSXMK
163
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $67.4M | 0.17% |
1,838,126
+262,590
| +17% | +$9.16M |
|
164
Micron Technology
MU
$988B
| $67.1M | 0.16% |
1,247,530
-93,700
| -7% | -$4.47M |
|
165
United Therapeutics
UTHR
$26.2B
| $66.1M | 0.16% |
750,000
+500,000
| +200% | +$44M |
|
166
Prologis
PLD
$136B
| $65.6M | 0.16% |
735,829
-31,400
| -4% | -$2.78M |
|
167
US Bancorp
USB
$98B
| $63.7M | 0.16% |
1,074,000
+133,400
| +14% | +$7.71M |
|
168
Assurant
AIZ
$14B
| $63.4M | 0.16% |
484,040
-23,400
| -5% | -$3.01M |
|
169
KeyCorp
KEY
$24.2B
| $63M | 0.15% |
3,110,511
-814,500
| -21% | -$15.4M |
|
|
CCMP
170
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $62.4M | 0.15% |
432,323
-5,256
| -1% | -$746K |
|
171
T-Mobile US
TMUS
$186B
| $62.1M | 0.15% |
791,850
+407,500
| +106% | +$32.1M |
|
172
Biogen
BIIB
$30.7B
| $61.9M | 0.15% |
+208,700
| New | +$57.9M |
|
173
CSX Corp
CSX
$93B
| $61.3M | 0.15% |
2,542,431
-372,873
| -13% | -$8.82M |
|
174
Deere & Co
DE
$162B
| $61.3M | 0.15% |
353,927
-592,647
| -63% | -$102M |
|
175
Enviri
NVRI
$624M
| $60.7M | 0.15% |
2,636,640
-57,681
| -2% | -$1.21M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.